Abstract:Background & aims: Addition of sialic acids (sialylation) to glycoconjugates is a common capping step of glycosylation. Our study aims to determine the roles of the overall sialylation in intestinal mucosal homeostasis. Methods: Mice with constitutive deletion of intestinal epithelial sialylation (IEC Slc35a1-/- mice) and mice with inducible deletion of sialylation in intestinal epithelium (TM-IEC Slc35a1-/- mice) were generated, which were used to determine the roles of overall sialylation in intestinal mucosal homeostasis by ex vivo and mutiomics studies. Results: IEC Slc35a1-/- mice developed mild spontaneous microbiota-dependent colitis. Additionally, 30% of IEC Slc35a1-/- mice had spontaneous tumors in the rectum greater than the age of 12 months. TM-IEC Slc35a1-/- mice were highly susceptible to acute inflammation induced by 1% dextran sulfate sodium versus control animals. Loss of total sialylation was associated with reduced mucus thickness on fecal sections and within colon tissues. TM-IEC Slc35a1-/- mice showed altered microbiota with an increase in Clostridia disporicum, which is associated a global reduction in the abundance of at least 20 unique taxa; however, metabolomic analysis did not show any significant differences in short-chain fatty acid levels. Treatment with 5-fluorouracil led to more severe small intestine mucositis in the IEC Slc35a1-/- mice versus wild-type littermates, which was associated with reduced Lgr5+ cell representation in small intestinal crypts in IEC Slc35a1-/-;Lgr5-GFP mice. Conclusions: Loss of overall sialylation impairs mucus stability and the stem cell niche leading to microbiota-dependent spontaneous colitis and tumorigenesis.

Sialylation in the gut: From mucosal protection to disease pathogenesis

Biological function of sialic acid and sialylation in human health and disease

Mechanistic and Therapeutic Implications of Protein and Lipid Sialylation in Human Diseases

Mucus sialylation determines intestinal host-commensal homeostasis

The effects of diet and gut microbiota on the regulation of intestinal mucin glycosylation

Sialylation regulates neutrophil transepithelial migration, CD11b/CD18 activation, and intestinal mucosal inflammatory function

Ablation of Intestinal Epithelial Sialylation Predisposes to Acute and Chronic Intestinal Inflammation in Mice

SUMOylation at the crossroads of gut health: insights into physiology and pathology

The role of glycans in health and disease: Regulators of the interaction between gut microbiota and host immune system

Insights into the Role of Sialylation in Cancer Metastasis, Immunity, and Therapeutic Opportunity

Sialylation: an Avenue to Target Cancer Cells

Insights into the Structure, Metabolism, Biological Functions and Molecular Mechanisms of Sialic Acid: A Review

Critical Roles of Bile Acids in Regulating Intestinal Mucosal Immune Responses

Mucin-Type O-Glycans: Barrier, Microbiota, and Immune Anchors in Inflammatory Bowel Disease

Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD

Sialylation shapes mucus architecture inhibiting bacterial invasion in the colon

Sialic acid metabolism of oral bacteria and its potential role in colorectal cancer and Alzheimer's disease

Analyzing and Modifying Sialic Acid at the Glycan End: Systematic Review of Methods and Functional Outcomes

Novel regulatory mechanisms of N-glycan sialylation: Implication of integrin and focal adhesion kinase in the regulation

The role of sialoglycans in modulating dendritic cell function and tumour immunity

Targeting epithelium-expressed sialyl Lewis glycans improves colonic mucosal wound healing and protects against colitis